FULC($290M) has a higher market cap than HRTX($59.9M). FULC YTD gains are higher at: -66.401 vs. HRTX (-75.731). HRTX has higher annual earnings (EBITDA): -16.78M vs. FULC (-85.4M). FULC has more cash in the bank: 319M vs. HRTX (42.7M). FULC has less debt than HRTX: FULC (5.28M) vs HRTX (148M). HRTX has higher revenues than FULC: HRTX (151M) vs FULC (0).

	FULC	HRTX	FULC / HRTX
Capitalization	290M	59.9M	484%
EBITDA	-85.4M	-16.78M	509%
Gain YTD	-66.401	-75.731	88%
P/E Ratio	N/A	N/A	-
Revenue	0	151M	-
Total Cash	319M	42.7M	747%
Total Debt	5.28M	148M	4%

FUNDAMENTALS RATINGS

FULC vs HRTX: Fundamental Ratings

	FULC	HRTX
OUTLOOK RATING 1..100	92	68
VALUATION overvalued / fair valued / undervalued 1..100	12 Undervalued	52 Fair valued
PROFIT vs RISK RATING 1..100	100	100
SMR RATING 1..100	97	100
PRICE GROWTH RATING 1..100	63	84
P/E GROWTH RATING 1..100	100	100
SEASONALITY SCORE 1..100	11	8

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FULC's Valuation (12) in the null industry is somewhat better than the same rating for HRTX (52) in the Biotechnology industry. This means that FULC’s stock grew somewhat faster than HRTX’s over the last 12 months.

FULC's Profit vs Risk Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to HRTX’s over the last 12 months.

FULC's SMR Rating (97) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to HRTX’s over the last 12 months.

FULC's Price Growth Rating (63) in the null industry is in the same range as HRTX (84) in the Biotechnology industry. This means that FULC’s stock grew similarly to HRTX’s over the last 12 months.

FULC's P/E Growth Rating (100) in the null industry is in the same range as HRTX (100) in the Biotechnology industry. This means that FULC’s stock grew similarly to HRTX’s over the last 12 months.

TECHNICAL ANALYSIS

Technical Analysis

	FULC	HRTX
RSI ODDS (%)	N/A	2 days ago 90%
Stochastic ODDS (%)	2 days ago 80%	2 days ago 90%
Momentum ODDS (%)	2 days ago 81%	2 days ago 80%
MACD ODDS (%)	2 days ago 74%	2 days ago 85%
TrendWeek ODDS (%)	2 days ago 83%	2 days ago 88%
TrendMonth ODDS (%)	2 days ago 86%	2 days ago 87%
Advances ODDS (%)	19 days ago 87%	5 days ago 84%
Declines ODDS (%)	10 days ago 84%	2 days ago 90%
BollingerBands ODDS (%)	2 days ago 86%	2 days ago 90%
Aroon ODDS (%)	2 days ago 78%	N/A

COMPARISON

Comparison

Sep 12, 2026

Stock price -- (FULC: $3.80 vs. HRTX: $0.32)

Brand notoriety: FULC and HRTX are both not notable

Both companies represent the Biotechnology industry

Current volume relative to the 65-day Moving Average: FULC: 44% vs. HRTX: 44%

Market capitalization -- FULC: $290.31M vs. HRTX: $59.9M

FULC [@Biotechnology] is valued at $290.31M. HRTX’s [@Biotechnology] market capitalization is $59.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FULC’s FA Score shows that 1 FA rating(s) are green while HRTX’s FA Score has 0 green FA rating(s).

FULC’s FA Score: 1 green, 4 red.
HRTX’s FA Score: 0 green, 5 red.

According to our system of comparison, FULC is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FULC’s TA Score shows that 6 TA indicator(s) are bullish while HRTX’s TA Score has 3 bullish TA indicator(s).

FULC’s TA Score: 6 bullish, 3 bearish.
HRTX’s TA Score: 3 bullish, 6 bearish.

According to our system of comparison, FULC is a better buy in the short-term than HRTX.

Price Growth

FULC (@Biotechnology) experienced а -1.30% price change this week, while HRTX (@Biotechnology) price change was -8.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

FULC is expected to report earnings on Oct 29, 2026.

HRTX is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three

FULC

Daily Signal:

Gain/Loss:

HRTX

Setup

Daily Signal:

Description

Gain/Loss:

Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)Swing Trader for Large Caps: Focusing on Intrinsic Value Metrics, 60 min, (FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
CVAIX	25.98	0.21	+0.81%
Calamos Select Fund I
EPGCX	17.29	N/A	N/A
Fidelity Advisor Equity Growth C
TIOSX	17.80	N/A	N/A
Nuveen International Opps A
RGORX	24.52	N/A	N/A
RBC Global Opportunities R6
PMIRX	11.56	N/A	N/A
Franklin Multi-Asset Income R

FULC and

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ABVX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ABVX could also see price increases.

Ticker / NAME	Correlation To FULC	1D Price Change %
FULC	100%	N/A
ABVX - FULC	54% Loosely correlated	+2.32%
HRTX - FULC	52% Loosely correlated	-2.11%
SLS - FULC	48% Loosely correlated	-14.42%
KYMR - FULC	41% Loosely correlated	-1.74%
WVE - FULC	40% Loosely correlated	-1.71%
More

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with FULC. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then FULC could also see price increases.

Ticker / NAME	Correlation To HRTX	1D Price Change %
HRTX	100%	-2.11%
FULC - HRTX	52% Loosely correlated	N/A
ABVX - HRTX	49% Loosely correlated	+2.32%
AMRN - HRTX	44% Loosely correlated	-1.71%
SION - HRTX	43% Loosely correlated	+3.02%
TENX - HRTX	42% Loosely correlated	-4.62%
More